Next Article in Journal
Willingness to Oppose Smoking among Pregnant Women
Next Article in Special Issue
Has the Volume-Based Drug Purchasing Approach Achieved Equilibrium among Various Stakeholders? Evidence from China
Previous Article in Journal
The Comparison of the Effects between Continuous and Intermittent Energy Restriction in Short-Term Bodyweight Loss for Sedentary Population: A Randomized, Double-Blind, Controlled Trial
Previous Article in Special Issue
Health Impact Assessments of Health Sector Proposals: An Audit and Narrative Synthesis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Health and Economic Impacts Assessment of O3 Exposure in Mexico

by
José Luis Texcalac-Sangrador
1,
Magali Hurtado-Díaz
1,
Eunice Elizabeth Félix-Arellano
1,
Carlos Manuel Guerrero-López
2 and
Horacio Riojas-Rodríguez
1,*
1
Environmental Health Department, National Institute of Public Health, Cuernavaca 62100, Mexico
2
Independent Researcher, Mexico City 03303, Mexico
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2021, 18(21), 11646; https://doi.org/10.3390/ijerph182111646
Submission received: 1 August 2021 / Revised: 22 October 2021 / Accepted: 28 October 2021 / Published: 5 November 2021
(This article belongs to the Special Issue Health Impact Assessment)

Abstract

:
Health effects related to exposure to air pollution such as ozone (O3) have been documented. The World Health Organization has recommended the use of the Sum of O3 Means Over 35 ppb (SOMO35) to perform Health Impact Assessments (HIA) for long-term exposure to O3. We estimated the avoidable mortality associated with long-term exposure to tropospheric O3 in 14 cities in Mexico using information for 2015. The economic valuation of avoidable deaths related to SOMO35 exposure was performed using the willingness to pay (WTP) and human capital (HC) approaches. We estimated that 627 deaths (95% uncertainty interval (UI): 227–1051) from respiratory diseases associated with the exposure to O3 would have been avoided in people over 30 years in the study area, which confirms the public health impacts of ambient air pollution. The avoidable deaths account for almost 1400 million USD under the WTP approach, whilst the HC method yielded a lost productivity estimate of 29.7 million USD due to premature deaths. Our findings represent the first evidence of the health impacts of O3 exposure in Mexico, using SOMO35 metrics.

1. Introduction

Air pollution is considered to be one of the main environmental risks to health around the world [1]. Several studies have documented the association between harmful effects on human health and exposure to air pollutants [2,3], among them ozone (O3).
O3 is a photochemical oxidant that may cause oxidative damage to the cells and lining fluids of airways, thus inducing immune-inflammatory responses and potentially causing adverse health effects [4]. Short-term effects, especially during the warm season, include hospital respiratory admissions [5], premature deaths [6], cardiovascular and respiratory mortality [7], as well as adverse effects on the central nervous system [8]. On the other hand, evidence of long-term effects includes increased asthma incidence [9]; reduced lung function and lung growth [10]; and an increased risk of low birth weight [11], lung cancer [12], and premature mortality [13].
Epidemiological studies provide evidence to support local governments and international organizations in implementing public policies which aim to reduce adverse health effects [14]. The results of these studies have been used to conduct Health Impact Assessments (HIA) worldwide. This type of assessment has been consolidated as a methodological tool to assist decision-makers in evaluating, quantitatively and qualitatively, how any policy, program, or project may affect human health (e.g., the impact of interventions on controlling air quality and reducing effects on human health) [15]. In addition, economic valuations of the adverse health effects of air pollution facilitate awareness of some of the consequences of public policies or the lack thereof. This, in turn, helps decision-makers to formulate and implement more consistent and explicitly informed policies, since putting health effects in terms of money makes it possible to assess interventions separately and to compare the costs and benefits of public policies that aim to reduce air pollution.
To perform HIAs of long-term exposure to O3, the World Health Organization (WHO) has recommended the use of the Sum of O3 Means Over 35 ppb (SOMO35) [16,17], which is defined as the annual sum of the daily maximum of the 8 h moving average over 35 ppb. This indicator emerged due to uncertainties in O3 studies regarding the effects of long-term exposure and the slope of the concentration–response function at lower concentrations [18], and it is a useful chronic exposure indicator for quantifying health impacts [19].
Several HIAs have been performed worldwide [20,21,22] using SOMO35 [19,23,24]; however, in Mexico, HIAs have focused on particulate matter [25]. The lack of information concerning SOMO35 health estimates and their associated costs has impeded the provision of information on the contribution of O3 exposure in excess of 35 ppb.
Although efforts have been made in Mexico to reduce O3 air pollution during recent years, only 21 out of 149 stations met the O3 national ambient air quality standard in 2018, and 74 stations exceeded the 1 h (0.095 ppm) and 8 h (0.07 ppm) limits. For example, the Mexico City Metropolitan Area (MCMA) exceeded the 1 h standard on 59.7% of days, followed by the Metropolitan Areas of Guadalajara (32.6%) and Monterrey (9.9%) [26].
The aim of this study was to assess the health and economic impacts of long-term O3 exposure in 14 Mexican cities for 2015. To our knowledge, this is the first HIA study using the SOMO35 metrics of O3 in Mexico.

2. Materials and Methods

An HIA was performed to estimate the avoidable mortality associated with long-term exposure to tropospheric O3 in 14 cities in Mexico using information from 2015 and following the WHO-HIA methodology [25,27,28,29]. Our analysis and estimates were carried out at the municipal level and aggregated by metropolitan or conurbation area, as defined by the National Urban System (SUN is its acronym in Spanish). Data processing, geographic layers, and estimates were performed using R version 3.3 (R Core Team, Vienna, Austria) and the RStudio Desktop version 1.1.463 (RStudio Team, Boston, MA, USA) software.

2.1. Air Pollution Data

Hourly O3 concentrations were obtained from the automatic monitoring stations of the National System of Air Quality Information (SINAICA is its acronym in Spanish) to estimate the annual sum of the daily maximum of the 8 h moving average over 35 ppb (SOMO35); this metric uses the concentration of 35 ppb as the O3 cut-off value. The daily maximum of the moving 8 h average O3 concentration was selected from each station when it met a minimum of 75% completeness of hourly data (18 h per day) for a minimum of 75% of the days of the year.
For each monitoring station, the SOMO35 indicator was estimated according to the following equations [17]:
S O M O 35 u n c o r r e c t e d = d = 1 d = N y max ( A 8 d 35 p p b , 0 )
Then:
S O M O 35 = S O M O 35 u n c o r r e c t e d × N y N V a l i d
where SOMO35uncorrected is the uncorrected SOMO35, A 8 d .   A 8 d is the maximum daily 8 h running average of O3 on day d, Ny is the total number of days for a year, and Nvalid is the number of days with available valid data. The hourly concentrations were treated accordingly to calculate the proper averages.

2.2. Cities Selection and Population Exposure

Each metropolitan or conurbation area comprises a varied number of municipalities, and these, in turn, comprise several basic geostatistical areas (for which AGEB is the acronym in Spanish). An AGEB is defined as a geographic space consisting of a set of blocks, generally ranging from 1 to 50 in number, delimited by streets, avenues, or any other features easily identifiable on the land and whose land use is mainly housing, industrial, services, or commercial. We selected only those municipalities with the spatial representativeness of O3 monitoring data. For this purpose, we selected the municipalities in which more than 50% of their AGEBs were located at intersections between the 5 km circular buffers that surrounded each of the O3 monitors.
The SOMO35 concentration was estimated at the municipal level through a spatial analysis and interpolation processes using geographic information layers in a shapefile format. First, monitoring stations were allocated according to their geographic coordinates and a 5 km circular buffer was created around each site. Second, intersection areas between the 5 km buffers were identified and the AGEB centroids located within them were selected; then, their SOMO35 concentration was estimated using square-weighted IDW. This step was replicated using 10 km buffer intersection areas, excluding the previously estimated centroids. Next, the non-estimated centroids located within each 10 km buffer intersection area were identified and assigned with the concentration from the monitoring station. Finally, the concentrations of the centroids that were not estimated in the previous steps were estimated using IDW with a weighting of 1. The final concentration of SOMO35 at the municipal level was calculated by adding and averaging the AGEB values. The concentration for each metropolitan area and/or conurbation was obtained by adding together the average concentrations obtained on the municipal scale.

2.3. Concentration–Response Function

We used the Concentration–Response Function (CRF) recommended by the WHO Regional Office for Europe (WHO-Europe); this was based on an exhaustive review of scientific evidence of the health effects of air pollution. The selected CRF indicates that an increase of 10 μg/m3 for the SOMO35 indicator increases the risk of death from respiratory causes (ICD-10 J00-J98) in people over 30 years of age by 1.014 (95% CI 1.005–1.024) [30].

2.4. Health and Demographic Data

Population and mortality data for 2015, at the municipality and AGEB level, organized by age group, were provided by the National Institute of Statistics and Geography (for which INEGI is the acronym in Spanish). Mortality data were aggregated by cause according to the CRF selected by municipality.

2.5. Avoidable Deaths

To estimate avoidable deaths from respiratory diseases associated with long-term O3 exposure, first the CRF was standardized to a unit of change using the following formula:
C R F = e l n ( R R ) / Δ C
where RR corresponds to the RR of the CRF and ∆C corresponds to the RR change unit. Then, the next equation was used:
A v o i d a b l e   d e a t h s = t o t a l   d e a t h s t o t a l   d e a t h s e ( [ ln C R F ]   *   S O M O 35 )
where Avoidable deaths corresponds to the deaths from respiratory diseases in the given age group, SOMO35 is the SOMO35 concentration, and CRF is the RR transformed into a unit of change.

2.6. Economic Assessment

The economic valuation of avoidable deaths from respiratory diseases related to SOMO35 exposure was performed using the willingness to pay (WTP) and human capital (HC) approaches. First, we estimated the value of a statistical life (VSL) by applying the following equation, as suggested by the Organization for Economic Cooperation and Development (OECD) [31].
V S L S 2015 = V S L O E C D 2015 * ( Y S 2015 Y O E C D 2015 ) β
where S is the city; VSL in OECD in 2015 is estimated to be 3.59 million USD after adjusting a previous VSL estimate [31]. for inflation [32]; Y is the gross domestic product (GDP) per capita in city S in 2015 gathered from the National Institute of Statistics and Geography [33]; and β is the income elasticity of 0.9 for middle-income countries [31]. For sensitivity purposes, we also calculated the VSL using β = 1.5 (lower value) and β = 0.5 (upper value for VSL). When a city included municipalities of more than 1 state, we calculated the GDP per capita weighting by the relative population within the city.
The HC perspective relies on the assumption that the flow of future annual productivities is lost because of premature death. We estimated the productivity loss at every age (Yd) of death in every city as the sum of future expected productivities obtained from the National Survey on Occupation and Employment (for which ENOE is the acronym in Spanish) [34]. ENOE included more than 1.15 million individual observations in the 4 quarters of 2015 at the national level. We used the Mincer equation to estimate expected annual productivity (Yage), adjusting by sex, age, the quarter of the year, age square, social security, schooling, and city among individuals with positive earnings, assuming 240 working 8 h days per year. To calculate the present values of future monetary figures, we discounted the expected productivities at a 3% annual rate:
Y d = ( t = 30 L E Y a g e ( 1 r ) t 30 )
where LE = life expectancy = 76 years, Yage = annual productivity at a certain age, t = age at death, and r = discount rate = 0.03. For deaths at ages older than 76 years, we assumed the lost productivity at 76 years old. We calculated the discounted expected productivities using 95% lower and upper confidence interval values to provide uncertainty analyses. To calculate the economic costs associated with mortality by O3, we multiplied the number of avoidable deaths within each city by the corresponding VSL and lost productivity at every age at death. We considered a purchasing power parity (PPP) of 8.33 MXN = 1 USD for both approaches [35].

3. Results

3.1. Study Area

The study area consisted of 67 municipalities distributed across 14 cities which, according to the SUN, correspond to the conurbations of Irapuato and Salamanca in the state of Guanajuato, and 12 metropolitan areas, all of them distributed in 11 states of the country; this area includes more than 33 million people (Figure 1).
Figure 1 shows the conurbations and metropolitan areas that, according to Mexican regulation, should monitor the air quality. It was not possible to include all of them in the analysis due to a lack of information or insufficient data in the monitoring stations.
Table 1 shows the number of municipalities included in the analysis, their cities, and their population. The total population of the 14 cities was 33,526,996 inhabitants; the Valle de Mexico, Guadalajara, and Monterrey had the largest populations of the cities included in the analysis.

3.2. Estimates of Exposure to O3

For 2015, it was possible to collect the information from 117 monitoring stations; however, only 59 (50.4%) met the criterion of a 75% sufficiency of data. Regarding O3 concentration, the municipalities of the metropolitan area of the Valle de Mexico, León, Celaya, and Irapuato presented the highest concentration considering the SOMO35 indicator (Table 1).

3.3. Economic and Health Impacts (Avoidable Deaths)

We estimated that 627 (9% UI: 227–1051) deaths from respiratory diseases associated with exposure to O3 would be avoided in people over 30 years in the study area—this represents 4% of the total deaths in the study area for the same cause and age group. The metropolitan area of the Valle de Mexico had the greatest impact, with 461 avoidable deaths (Table 2); Mexico City alone accounts for 66% of this total and exceeds the metropolitan area of Guadalajara, which occupies the second position.
Avoidable deaths account for almost 1400 million USD under the WTP approach, whilst the HC methods yielded a lost productivity estimate of 29.7 million USD caused by premature deaths and the central (point) estimates. Table S1 shows the productivity lost by city and age.

4. Discussion

This study represents the first quantification of the health impacts attributable to long-term O3 exposure in Mexican cities using the indicator recommended by the World Health Organization (SOMO35). The avoidable deaths for respiratory diseases associated with O3 exposure amount to 627 deaths in the study area, which confirms the public health impacts of ambient air pollution.
SOMO35 levels vary between metropolitan areas, but the MCMA, the most populated city, stands out with the highest concentration and contribution to the estimates of avoidable deaths. It is important to mention that the meteorological conditions in this region, along with the presence of precursor emissions, promote the formation of O3 during half of the year. However, although some cities have relatively high O3 concentrations, such as Salamanca, they did not represent a high contribution to avoidable deaths.
So far, the metrics used to evaluate the health effects associated with O3 exposure are primarily acute (1 h or 8 h moving averages), and studies of long-term exposure to O3 are based on the annual or warm season average of daily 8 h maximum concentrations [13,36]. This approach implies the use of higher concentrations compared to SOMO35, which is an indicator of the accumulated O3 concentration in excess of 35 ppb (70 μg/m3) during the whole year. The difference between these approaches represents a significant element in estimating deaths attributable to O3 exposure. Moreover, SOMO35 is a useful indicator for quantifying the health impacts of long-term exposure to O3 and a reliable procedure for estimating mortality attributable to O3 [37]; it has been used by the international scientific community [19,38], and therefore our results are likely to be highly reliable.
For 2015, the GBD estimated more than 1991 deaths (888–3247) attributable to environmental exposure to O3 for Mexico while we estimated 627 deaths. There are important differences between both studies such as the study area, the metrics of the exposure, and the causes of mortality. Our study is based on measurements from monitoring stations in 14 cities, uses the SOMO35 metric, and considers only deaths from respiratory diseases. Meanwhile, the GBD is based on chemical transport models for the entire country, uses the running 3-month (summer) mean of O3 concentration (of daily 1 h maximum values) as the metric of exposure, and selects the maximum of these values for each 0.1 × 0.1° (∼11 km × 11 km) over 1 year. Furthermore, the GDB considers only Chronic Obstructive Pulmonary Disease (COPD) as a specific cause for analysis. The GBD results are higher because of these differences.
In Mexico, a previous study called the “Central Region Study” quantified the avoidable deaths attributable to O3 exposure using a different approach [39]. It included seven states, with a population of 25 million inhabitants, and most of the cities with high O3 concentrations in Mexico. This study reports a total of 1067 avoidable deaths in contrast to our estimate of 627 deaths. Once more, the metrics to evaluate O3 exposure play an important role. The “Central Region Study” uses an annual O3 average concentration which is calculated from the maximum 8-h moving O3 averages, and a counterfactual scenario of 50 ppb. We used the SOMO35 indicator which is an optimal alternative to estimate chronic exposure; it uses the information from every day with moderate and constantly high O3 concentrations and not only the days with very high concentrations. In general, studies using different approaches from SOMO35 tend to overestimate the attributable deaths.
To contrast our results with different cut points, we used SOMO50 and SOMO0. The deaths attributable to respiratory diseases associated with exposure to O3 were estimated using the SOMO50 (exceeds of 50 ppb). The avoidable deaths attributable to O3 exposure decreased from 627 to 275 deaths, which is almost a 50% difference. The opposite extreme implies estimating avoidable deaths without considering a background concentration and without removing any excess, which is known as SOMO0. Under this consideration, the avoidable deaths attributable to O3 exposure would increase to 994. This difference reveals the importance of selecting the exposure metric and its counterfactual value when generating impact estimates. In September 2021, the WHO released new air quality guidelines (WHO-AQG), specifying 60 ug/m3 (30 ppb) as the limit value for O3 long-term exposure; using this concentration as a cut-off point, we observe that 782 deaths could have been avoided in 2015. It means that health impacts of this cut-off would be greater since, on average, 150 additional deaths would be avoided, compared to the estimates using 70 ug/m3 as the cut-off point.
As already mentioned, the SOMO35 indicator is calculated from the selection of the highest concentration of the moving averages of 8 h of each day; this value may vary depending on the weather season and other factors.
Our estimates of respiratory diseases associated with the exposure to O3 may be added to those already calculated for PM2.5 exposure. As Trejo et al. pointed out [25], these respirable particles generate more than 14,600 avoidable deaths per year considering only those cities with sufficient data to perform the evaluation. Unlike our study, Trejo et al. used information from 15 cities with a larger population, and in which the set of diseases related to exposure to PM2.5 was larger, the CRF was different, and the age groups were wider. However, both studies are complementary and are useful for pointing out the mortality attributable to air pollution in Mexico.
With respect to economic valuation, we offer two types of estimates that rely on different theoretical backgrounds, and thus produce estimates of different orders of magnitude. Usually, VSL estimates present a wide range of values depending on assumptions and methods, as discussed elsewhere [25]. Although the ideal way to calculate a VSL in Mexico is to use reliable stated preferences studies concerning money–risk tradeoffs, no large, representative surveys exist in Mexico on that subject; thus, this is one major limitation of this study. However, our estimates are based on the systematic review and methods outlined by the OECD in order to transfer a base VSL to Mexico and in order to calculate specific VSLs for the cities included in this study, taking into account heterogeneity in GDP per capita among them, as suggested by Hammit [40]. We estimated a VSL of 1.76 million USD at the national level (this estimate is not included in Table 2, but is used here for comparison purposes), which is not far from the 1.671 million USD calculated by Viscusi et al. [41] for Mexico in 2015. The same study found that the average VSL for upper middle-income countries was 1.2 million USD. On the other hand, the HC approach represents lost productivity caused by premature death. Our calculations were performed using the standard methods and the best available sources of information on employment and wages in Mexico. The costs of mortality, which we calculated using the WTP approach, accounts for 0.113% of the GDP in 2015 in the States where the cities analyzed are located. Among policy analysts, the VSL is generally considered to be an economically adequate measure of the benefit individuals receive from enhancements to their health or safety [42]. Although the estimates made using the HC approach seem negligible compared with VSL estimates, we argue that this information provides further valuable evidence of the economic consequences of air pollution. A previous study performed in Mexico on preventable deaths related to exposure to PM2.5 also produced estimates for the VSL in Mexico in 2015 [25]. The main difference of the point estimate in that study (1.643 million USD) compared to our new estimate (1.76 million USD) is that we used updated GDP per capita data by state. Moreover, in the current study, we were able to estimate the cost of avoidable deaths using the WTP approach by calculating the specific VSL for every city included, and therefore this is one of the main improvements of this study.
Limitations: our estimates are based on the measurements from monitoring stations whose operation occurs irregularly over time. This limits the number of monitoring stations with available information to calculate SOMO35, as well as the number of cities and metropolitan areas that can be studied. If there were better monitoring coverage and consistency in measurements, the estimated impacts would be greater. However, the analysis includes the metropolitan areas that historically have had the highest levels of O3.
Recommendations: an estimate of the burden attributable to O3 exposure morbidity in Mexican cities is recommended. Although we know that the greatest burden occurs due to avoidable mortality, the increase in signs, symptoms, and respiratory diseases can rise significantly in these cities during the warm season. The results would be useful for local air quality improvement programs.

5. Conclusions

Our findings represent the first evidence of the health impacts of O3 exposure using the SOMO35 metrics in Mexico. The implementation of the HIA method using SOMO35 allows us to quantify the magnitude of avoidable deaths from respiratory diseases associated with long-term exposure to O3 in the Mexican population and its associated economic costs, considering 2015 as a reference. Likewise, our study evidences this impact at different scales within the geostatistical and urban frameworks of Mexico, constituting a support document for decision making at various scales of the territory.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/ijerph182111646/s1, Table S1: Productivity lost (Yd).

Author Contributions

Conceptualization, J.L.T.-S. and H.R.-R.; methodology, J.L.T.-S., H.R.-R., M.H.-D., C.M.G.-L., and E.E.F.-A.; software, J.L.T.-S.; validation, J.L.T.-S., H.R.-R., M.H.-D., C.M.G.-L., and E.E.F.-A.; formal analysis, J.L.T.-S., H.R.-R., M.H.-D., C.M.G.-L., and E.E.F.-A.; investigation, J.L.T.-S. and H.R.-R.; data curation, J.L.T.-S.; writing—review and editing, J.L.T.-S., H.R.-R., M.H.-D., C.M.G.-L., and E.E.F.-A.; supervision, J.L.T.-S., H.R.-R., M.H.-D., C.M.G.-L., and E.E.F.-A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable as the health data used in the study are from an administrative database.

Data Availability Statement

The data presented in this study are openly available in Harvard Dataverse at (https://doi.org/10.7910/DVN/PXVSHA (accessed on 21 October 2021).

Acknowledgments

We thank Adrián Giovani Trejo-González for his assistance in the management of geographic information and Karla Cervantes-Martínez for her assistance in the calculation of estimates and equations. We also thank Jaquelin Martinez-Aviles for her assistance in editing the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: A systematic analysis for the Global Burden of Diseases Study 20. Lancet 2016, 388, 1659–1724. [Google Scholar] [CrossRef] [Green Version]
  2. Mannucci, P.M.; Harari, S.; Martinelli, I.; Franchini, M. Effects on health of air pollution: A narrative review. Intern. Emerg. Med. 2015, 10, 657–662. [Google Scholar] [CrossRef]
  3. Sun, Z.; Zhu, D. Exposure to outdoor air pollution and its human health outcomes: A scoping review. PLoS ONE 2019, 14, e0216550. [Google Scholar] [CrossRef]
  4. Zhang, J.J.; Wei, Y.; Fang, Z. Ozone pollution: A major health hazard worldwide. Front. Immunol. 2019, 10, 2518. [Google Scholar] [CrossRef] [Green Version]
  5. Ji, M.; Cohan, D.S.; Bell, M.L. Meta-analysis of the association between short-term exposure to ambient ozone and respiratory hospital admissions. Environ. Res. Lett. 2011, 6, 024006. [Google Scholar] [CrossRef]
  6. Nawahda, A.; Yamashita, K.; Ohara, T.; Kurokawa, J.; Ohizumi, T.; Chen, F.; Akimoto, H. Premature mortality in Japan due to ozone. Atmos. Environ. 2013, 81, 538–545. [Google Scholar] [CrossRef]
  7. Pascal, M.; Wagner, V.; Chatignoux, E.; Falq, G.; Corso, M.; Blanchard, M.; Host, S.; Larrieu, S.; Pascal, L.; Declercq, C. Ozone and short-term mortality in nine French cities: Influence of temperature and season. Atmos. Environ. 2012, 62, 566–572. [Google Scholar] [CrossRef]
  8. Martínez-Lazcano, J.C.; González-Guevara, E.; Del Carmen Rubio, M.; Franco-Pérez, J.; Custodio, V.; Hernández-Cerón, M.; Livera, C.; Paz, C. The effects of ozone exposure and associated injury mechanisms on the central nervous system. Rev. Neurosci. 2013, 24, 337–352. [Google Scholar] [CrossRef] [PubMed]
  9. Zu, K.; Shi, L.; Prueitt, R.L.; Liu, X.; Goodman, J.E. Critical review of long-term ozone exposure and asthma development. Inhal. Toxicol. 2018, 30, 99–113. [Google Scholar] [CrossRef] [PubMed]
  10. Dimakopoulou, K.; Douros, J.; Samoli, E.; Karakatsani, A.; Rodopoulou, S.; Papakosta, D.; Grivas, G.; Tsilingiridis, G.; Mudway, I.; Moussiopoulos, N.; et al. Long-term exposure to ozone and children’s respiratory health: Results from the RESPOZE study. Environ. Res. 2020, 182, 109002. [Google Scholar] [CrossRef] [PubMed]
  11. Wang, Q.; Miao, H.; Warren, J.L.; Ren, M.; Benmarhnia, T.; Knibbs, L.D.; Zhang, H.; Zhao, Q.; Huang, C. Association of maternal ozone exposure with term low birth weight and susceptible window identification. Environ. Int. 2021, 146, 106208. [Google Scholar] [CrossRef]
  12. Kazemiparkouhi, F.; Eum, K.D.; Wang, B.; Manjourides, J.; Suh, H.H. Long-term ozone exposures and cause-specific mortality in a US Medicare cohort. J. Expo. Sci. Environ. Epidemiol. 2020, 30, 650–658. [Google Scholar] [CrossRef] [Green Version]
  13. Lim, C.C.; Hayes, R.B.; Ahn, J.; Shao, Y.; Silverman, D.T.; Jones, R.R.; Garcia, C.; Bell, M.L.; Thurston, G.D. Long-term exposure to ozone and cause-specific mortality risk in the United States. Am. J. Respir. Crit. Care Med. 2019, 200, 1022–1031. [Google Scholar] [CrossRef] [PubMed]
  14. Boldo, E.; Linares, C.; Lumbreras, J.; Borge, R.; Narros, A.; García-Pérez, J.; Fernández-Navarro, P.; Pérez-Gómez, B.; Aragonés, N.; Ramis, R.; et al. Health impact assessment of a reduction in ambient PM2.5 levels in Spain. Environ. Int. 2011, 37, 342–348. [Google Scholar] [CrossRef]
  15. Nuvolone, D.; Petri, D.; Voller, F. The effects of ozone on human health. Environ. Sci. Pollut. Res. 2018, 25, 8074–8088. [Google Scholar] [CrossRef] [PubMed]
  16. World Health Organization (WHO). Review of Evidence on Health Aspects of Air Pollution—REVIHAAP; World Health Organization: Geneva, Switzerland, 2013. [Google Scholar]
  17. World Health Organization (WHO). Health Risk of Ozone from Long-Range Transboundary Air Pollution; World Health Organization: Geneva, Switzerland, 2008. [Google Scholar]
  18. Rabl, A.; Spadaro, J.V.; Holland, M. How Much Is Clean Air Worth? Calculating the Benefits of Pollution Control; Cambridge University Press: Cambridge, UK, 2014. [Google Scholar]
  19. Karimi, A.; Shirmardi, M.; Hadei, M.; Birgani, Y.T.; Neisi, A.; Takdastan, A.; Goudarzi, G. Concentrations and health effects of short- and long-term exposure to PM2.5, NO2, and O3 in ambient air of Ahvaz city, Iran (2014–2017). Ecotoxicol. Environ. Saf. 2019, 180, 542–548. [Google Scholar] [CrossRef] [PubMed]
  20. Malmqvist, E.; Oudin, A.; Pascal, M.; Medina, S. Choices behind Numbers: A Review of the Major Air Pollution Health Impact Assessments in Europe. Curr. Environ. Health Rep. 2018, 5, 34–43. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Thondoo, M.; Rojas-Rueda, D.; Gupta, J.; De Vries, D.H.; Nieuwenhuijsen, M.J. Systematic Literature Review of Health Impact Assessments in Low and Middle-Income Countries Keywords: Health impact assessment (HIA); systematic review; process evaluation; low and middle-income country. Int. J. Environ. Res. Public Health 2019, 16, 2018. [Google Scholar] [CrossRef] [Green Version]
  22. Martenies, S.E.; Wilkins, D.; Batterman, S.A. Health impact metrics for air pollution management strategies. Environ. Int. 2015, 85, 84–95. [Google Scholar] [CrossRef] [Green Version]
  23. Lehtomäki, H.; Korhonen, A.; Asikainen, A.; Karvosenoja, N.; Kupiainen, K.; Paunu, V.V.; Savolahti, M.; Sofiev, M.; Palamarchuk, Y.; Karppinen, A.; et al. Health impacts of ambient air pollution in Finland. Int. J. Environ. Res. Public Health 2018, 15, 736. [Google Scholar] [CrossRef] [Green Version]
  24. Hadei, M.; Hopke, P.K.; Shahsavani, A.; Jahanmehr, N.; Rahmatinia, M.; Farhadi, M.; Yarahmadi, M.; Kermani, M. Mortality and morbidity economic burden due to PM2.5 and ozone; an AirQ+ modelling in Iran. J. Air Pollut. Health 2020, 5, 1–10. [Google Scholar] [CrossRef]
  25. Trejo-González, A.G.; Riojas-Rodriguez, H.; Texcalac-Sangrador, J.L.; Guerrero-López, C.M.; Cervantes-Martínez, K.; Hurtado-Díaz, M.; de la Sierra-de la Vega, L.A.; Zuñiga-Bello, P.E. Quantifying health impacts and economic costs of PM2.5 exposure in Mexican cities of the National Urban System. Int. J. Public Health 2019, 64, 561–572. [Google Scholar] [CrossRef]
  26. Instituto Nacional de Ecología y Cambio Climático. Informe Nacional de Calidad del Aire 2018, México; Coordinación General de Contaminación y Salud Ambiental, Dirección de Investigación de Calidad del Aire y Contaminantes Climáticos: Ciudad de México, México, 2019. [Google Scholar]
  27. Medina, S.; Ballester, F.; Chanel, O.; Declercq, C.; Pascal, M. Quantifying the health impacts of outdoor air pollution: Useful estimations for public health action. J. Epidemiol. Community Health 2013, 67, 480–483. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Castro, A.; Künzli, N.; Götschi, T. Health benefits of a reduction of PM10 and NO2 exposure after implementing a clean air plan in the Agglomeration Lausanne-Morges. Int. J. Hyg. Environ. Health 2017, 220, 829–839. [Google Scholar] [CrossRef]
  29. Bacigalupe, A.; Esnaola, S.; Calderón, C.; Zuazagoitia, J.; Aldasoro, E. La evaluación del impacto sobre la salud: Una herramienta para incorporar la salud en las intervenciones no sanitarias. Gac. Sanit. 2009, 23, 62–66. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Héroux, M.E.; Anderson, H.R.; Atkinson, R.; Brunekreef, B.; Cohen, A.; Forastiere, F.; Hurley, F.; Katsouyanni, K.; Krewski, D.; Krzyzanowski, M.; et al. Quantifying the health impacts of ambient air pollutants: Recommendations of a WHO/Europe project. Int. J. Public Health 2015, 60, 619–627. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. OECD. The Economic Consequences of Outdoor Air Pollution; OECD: Paris, France, 2016; ISBN 9789264257474. [Google Scholar]
  32. The World Bank GDP Deflator (Base Year Varies by Country). Available online: https://data.worldbank.org/indicator/NY.GDP.DEFL.ZS (accessed on 3 May 2021).
  33. INEGI. PIB Por Entidad Federativa (PIBE). Base. 2013. Available online: https://www.inegi.org.mx/programas/pibent/2013/ (accessed on 3 May 2021).
  34. INEGI. Encuesta Nacional de Ocupación y Empleo (ENOE). Población de 15 Años y Más de Edad. Available online: https://www.inegi.org.mx/programas/enoe/15ymas/ (accessed on 3 May 2021).
  35. OECD. Purchasing Power Parities (PPP). Available online: https://data.oecd.org/conversion/purchasing-power-parities-ppp.htm (accessed on 3 May 2021).
  36. Turner, M.C.; Jerrett, M.; Arden, C.; Krewski, D.; Gapstur, S.M.; Diver, R.; Beckerman, B.S.; Marshall, J.D.; Su, J.; Crouse, D.L.; et al. Long-Term Ozone Exposure and Mortality in a Large Prospective Study. Am. J. Respir. Crit. Care Med. 2016, 193, 1134–1142. [Google Scholar] [CrossRef] [Green Version]
  37. Valuntaitė, V.; Girgždienė, R. Nivo ozona u otvorenom i zatvorenom prostoru-mogući uticaj na zdravlje ljudi [Outdoor and indoor ozone level-A potential impact on human health]. Vojn. Pregl. 2015, 78, 696–701. [Google Scholar] [CrossRef]
  38. Martuzzi, M.; Mitis, F.; Iavarone, I.; Serinelli, M. Impatto sanitario dell’ozono in 13 città italiane [Health impact of ozone in 13 Italian cities]. Epidemiol. Prev. 2007, 31, 323–332. [Google Scholar]
  39. Instituto Nacional de Salud Pública. Estimación de Impactos en la Salud Por Contaminación Atmosférica en la Región Centro del País y Alternativas de Gestión; Coordinación General de Contaminación y Salud Ambiental: Mexico City, Mexico, 2016. [Google Scholar]
  40. Hammitt, J.K. Extrapolating the Value per Statistical Life Between Populations: Theoretical Implications. J. Benefit-Cost Anal. 2017, 8, 215–225. [Google Scholar] [CrossRef] [Green Version]
  41. Viscusi, W.K.; Masterman, C.J. Income Elasticities and Global Values of a Statistical Life. J. Benefit-Cost Anal. 2017, 8, 226–250. [Google Scholar] [CrossRef] [Green Version]
  42. Kniesner, T.J.; Viscusi, W.K. The Value of a Statistical Life. Oxford Research Encyclopedia of Economics and Finance. Available online: https://oxfordre.com/economics/view/10.1093/acrefore/9780190625979.001.0001/acrefore-9780190625979-e-138 (accessed on 21 October 2021).
Figure 1. Study areas.
Figure 1. Study areas.
Ijerph 18 11646 g001
Table 1. Number of municipalities and population in the cities included in the study, 2015.
Table 1. Number of municipalities and population in the cities included in the study, 2015.
StateCityPopulationPopulation > 30 YearsMortality Rate aMunSOMO35 by Mun
Mean
(Min–Max)
Nuevo LeónMonterrey *3,615,0751,810,79385.277.82
(5.74–13.4)
Coahuila
Durango
La Laguna *1,174,885556,66577.531.5
NayaritTepic *471,026217,43676.726.4
JaliscoGuadalajara *4,725,6032,194,98990.667.63
(5.98–9.16)
GuanajuatoLeón *1,768,193771,13077.5216.1
(16.1–16.6)
GuanajuatoIrapuato 574,344251,29191.0119.4
GuanajuatoSalamanca 273,271134,16274.1116.3
GuanajuatoCelaya *494,304227,15755.9119.1
MoreliaMorelia *784,776371,420115.819.2
HidalgoPachuca *427,551210,42280.9215.5
HidalgoTula *68,24732,22277.8212.2
Estado de MexicoToluca *1,512,455712,06386.058.22
(7.46–9.71)
Mexico City
Estado de Mexico
Valle de Mexico *17,156,4259,157,79890.33320.8
(8.9–29.0)
VeracruzXalapa *480,841241,69381.914.5
Total 33,526,99616,889,24185.26714.8
(1.5–29.0)
a: Mortality rate from respiratory causes; *: metropolitan area; : conurbation; Mun: municipalities; SOMO35 concentration in ppb; min: minimum; max: maximum.
Table 2. Annual avoidable deaths from respiratory diseases associated with exposure to O3, 2015 a.
Table 2. Annual avoidable deaths from respiratory diseases associated with exposure to O3, 2015 a.
CityAvoidable Deaths
(95% UI)
Economic Valuation b
(Min–Max)
Lost Productivity (USD)
Irapuato11 (4–18)$15.9 (8.7–23.8)$311,673.4 (228,810.7–394,536.1)
Salamanca4 (2–7)$5.8 (3.2–8.7)$142,685.1 (113,212–173,821.5)
La Laguna1 (0–3)$2.0 (1.4–2.5)$78,669.9 (70,110.1–87,229.6)
Valle de Mexico461 (166–767)$1106.3 (962.4–1278.7)$22,395,473.2 (21,018,939–23,772,007.4)
Celaya9 (3–15)$13.0 (7.1–19.5)$357,668.0 (264,351.7–450,984.3)
León30 (11–51)$43.4 (23.7–65.0)$1,103,163.9 (1,008,491.8–1,197,836.1)
Pachuca6 (3–10)$7.3 (3.5–11.8)$315,349.6 (286,099.3–344,599.8)
Tula000
Guadalajara50 (19–86)$88.2 (54.9–120.9)$2,235,794.5 (2,107,509.1–2,364,079.9)
Toluca12 (4–20)$14.0 (6.6–23.1)$475,383.0 (424,168.1–526,597.9)
Morelia7 (2–11)$7.6 (3.4–12.9)$257,349.4 (234,074.5–280,624.4)
Tepic3 (1–6)$3.7 (1.8–6.0)$96,211.8 (87,603.2–104,820.4)
Monterrey31 (11–53)$88.2 (75.6–97.8)$1,854,470.6 (1,761,086.9–1,947,854.3)
Xalapa2 (1–4)$2.5 (1.2–4.0)$62,171.7 (43,690.6–82,601.2)
Total627 (227–1051)$1397.8 (1153.6–1674.6)$29,686,064.1 (27,648,147–31,727,592.9)
a: Population ≥ 30 years of age; b: economic valuation of avoidable deaths (WTP approach, millions USD); USD: United States Dollars; min: minimum; max: maximum: 95% UI: 95% uncertainty interval. Calculations were made using point estimates of avoidable deaths.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Texcalac-Sangrador, J.L.; Hurtado-Díaz, M.; Félix-Arellano, E.E.; Guerrero-López, C.M.; Riojas-Rodríguez, H. Health and Economic Impacts Assessment of O3 Exposure in Mexico. Int. J. Environ. Res. Public Health 2021, 18, 11646. https://doi.org/10.3390/ijerph182111646

AMA Style

Texcalac-Sangrador JL, Hurtado-Díaz M, Félix-Arellano EE, Guerrero-López CM, Riojas-Rodríguez H. Health and Economic Impacts Assessment of O3 Exposure in Mexico. International Journal of Environmental Research and Public Health. 2021; 18(21):11646. https://doi.org/10.3390/ijerph182111646

Chicago/Turabian Style

Texcalac-Sangrador, José Luis, Magali Hurtado-Díaz, Eunice Elizabeth Félix-Arellano, Carlos Manuel Guerrero-López, and Horacio Riojas-Rodríguez. 2021. "Health and Economic Impacts Assessment of O3 Exposure in Mexico" International Journal of Environmental Research and Public Health 18, no. 21: 11646. https://doi.org/10.3390/ijerph182111646

APA Style

Texcalac-Sangrador, J. L., Hurtado-Díaz, M., Félix-Arellano, E. E., Guerrero-López, C. M., & Riojas-Rodríguez, H. (2021). Health and Economic Impacts Assessment of O3 Exposure in Mexico. International Journal of Environmental Research and Public Health, 18(21), 11646. https://doi.org/10.3390/ijerph182111646

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop